Now showing items 1-2 of 2

  • PHARMACOKINETIC STRATEGIES TO OPTIMIZE IP CHEMOTHERAPY 

    BALTHASAR, JOSEPH P Principal Investigator (2011-04-18)
    DESCRIPTION (provided by applicant): Ovarian cancer is the leading cause of gynecologic cancer death in the United States, and there is substantial need for the development of improved strategies to treat this disease. The ...
  • PHARMACOLOGY AND BIOENGINEERING OF NEW TREATMENT OF ITP 

    BALTHASAR, JOSEPH P Principal Investigator (2011-04-18)
    DESCRIPTION (provided by applicant): Immune thrombocytopenic purpura (ITP) is a common autoimmune disease that is associated with ~50,000 new cases each year in the United States. Approximately 25-30% of chronic ITP patients ...